Voyageur Pharmaceuticals Ltd (V:VM) — Market Cap & Net Worth
Market Cap & Net Worth: Voyageur Pharmaceuticals Ltd (VM)
Voyageur Pharmaceuticals Ltd (V:VM) has a market capitalization of $14.21 Million (CA$19.64 Million) as of May 2, 2026. Listed on the V stock exchange, this Canada-based company holds position #25996 globally and #1059 in its home market, demonstrating a 10.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Voyageur Pharmaceuticals Ltd's stock price CA$0.11 by its total outstanding shares 178586978 (178.59 Million). Analyse Voyageur Pharmaceuticals Ltd (VM) cash flow conversion to see how efficiently the company converts income to cash.
Voyageur Pharmaceuticals Ltd Market Cap History: 2015 to 2026
Voyageur Pharmaceuticals Ltd's market capitalization history from 2015 to 2026. Data shows growth from $12.92 Million to $14.21 Million (0.91% CAGR).
Voyageur Pharmaceuticals Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Voyageur Pharmaceuticals Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1879.49x
Voyageur Pharmaceuticals Ltd's market cap is 1879.49 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $21.96 Million | $11.69K | -$3.53 Million | 1879.49x | N/A |
Competitor Companies of VM by Market Capitalization
Companies near Voyageur Pharmaceuticals Ltd in the global market cap rankings as of May 2, 2026.
Key companies related to Voyageur Pharmaceuticals Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.09 |
Voyageur Pharmaceuticals Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Voyageur Pharmaceuticals Ltd's market cap moved from $12.92 Million to $ 14.21 Million, with a yearly change of 0.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$14.21 Million | -35.29% |
| 2025 | CA$21.96 Million | +100.00% |
| 2024 | CA$10.98 Million | +13.33% |
| 2023 | CA$9.69 Million | -11.76% |
| 2022 | CA$10.98 Million | -5.56% |
| 2021 | CA$11.63 Million | +28.57% |
| 2020 | CA$9.04 Million | -12.50% |
| 2019 | CA$10.33 Million | +14.29% |
| 2018 | CA$9.04 Million | -30.00% |
| 2017 | CA$12.92 Million | 0.00% |
| 2016 | CA$12.92 Million | 0.00% |
| 2015 | CA$12.92 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Voyageur Pharmaceuticals Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.21 Million USD |
| MoneyControl | $14.21 Million USD |
| MarketWatch | $14.21 Million USD |
| marketcap.company | $14.21 Million USD |
| Reuters | $14.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Voyageur Pharmaceuticals Ltd
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The co… Read more